CoreWeave, Inc. SEC Filings

CoreWeave, Inc. filed a Rule 144 notice reporting a proposed sale of 78,548 Class A common shares through Morgan Stanley Smith Barney, with an aggregate market value of $10,952,733.12 and an approximate sale date of 09/30/2025. The shares were acquired the same day as restricted stock units issued as compensation. The filing also discloses multiple Rule 10b5-1 sales by related parties totaling 247,365 shares over Aug–Sep 2025, which generated gross proceeds of $28,374,033.65.

Form 144 for CoreWeave, Inc. (CRWV) discloses a proposed sale of 150,000 common shares through Morgan Stanley Smith Barney LLC, scheduled approximately for 09/30/2025 with an aggregate market value of $18,378,000.00. The filer reports these shares were acquired as Founders Shares on 11/13/2017. The filing shows numerous recent executions of 10b5-1 sales by related parties on dates in August and September 2025, each selling blocks of 250,000 and 375,000 shares with multi-million dollar gross proceeds. The filing includes the filer’s representation regarding absence of undisclosed material adverse information and references Rule 10b5-1 trading plans where indicated.

Form 144 notice for CoreWeave, Inc. (CRWV) reports a proposed sale of 157,903 common shares through Morgan Stanley Smith Barney, with an aggregate market value of $19,346,275.56, from a total of 370,470,348 shares outstanding. The approximate date of sale is 09/30/2025. The filing shows the securities to be sold consist of 100,000 founders shares acquired 11/13/2017 and 57,903 restricted stock units granted as compensation on 09/30/2025.

The notice also discloses a series of Rule 10b5-1 sales by Brannin McBee and the Brannin J. McBee 2022 IRR Trust during August and September 2025; the filing lists 12 separate 10b5-1 sale entries with individual gross proceeds shown for each trade. The filer certifies no undisclosed material adverse information and references compliance with Rule 144 and any applicable 10b5-1 plan.

Michael N. Intrator, CoreWeave (CRWV) CEO, reported transactions on 09/24/2025. He acquired 50,000 Class B shares (convertible into Class A) and executed multiple sales of Class A shares through Omnadora Capital LLC under a Rule 10b5-1 plan adopted May 23, 2025. The sales were executed in multiple tranches at weighted-average prices reported in ranges from $124.47 to $133.41 per share across the transactions listed. The filing shows various beneficial ownership positions after each sale and lists material holdings tied to Omnadora and several trusts and family vehicles, including 21,867,489 Class A (direct) and 25,499,280 Class A (indirect) positions referenced for different holdings.

CoreWeave, Inc. (CRWV) Form 4 disclosure describes multiple insider sales by affiliated reporting persons tied to Magnetar entities and an individual manager. On 09/25/2025 the filing reports a series of dispositions totaling 185,627 shares of Class A common stock sold across multiple transactions at weighted-average prices in the range of roughly $135.94 to $138.00 per share. The reporting chain shows Magnetar Financial LLC, Magnetar Capital Partners LP, Supernova Management LLC and David J. Snyderman as related reporting persons, with the sold shares held by various Magnetar funds. After the transactions the filing shows an indicated indirect beneficial ownership position of 9,202,863 shares for certain affiliated accounts. The filing includes detailed footnotes explaining the fund relationships and weighted-average price ranges.

Magnetar-related entities and David J. Snyderman reported multiple dispositions of CoreWeave, Inc. (CRWV) Class A common stock on 09/25/2025. The Form 4 shows numerous sales in separate blocks at weighted-average prices ranging roughly from $133.50 to $138.00 per share. The filings identify Magnetar Financial LLC, Magnetar Capital Partners LP, Supernova Management LLC and David J. Snyderman as reporting persons, each noted as a director and a 10% owner or connected to such funds. The report lists the number of shares beneficially owned following each reported sale for various underlying funds and accounts and includes footnotes describing the holding entities and price ranges.

CoreWeave officer McBee reported multiple transactions on 09/23/2025 involving both Class A and Class B common stock. The filing shows conversions of 250,000 and 375,000 shares of Class B into Class A, and a series of sales under a Rule 10b5-1 plan that disposed of many Class A shares in tranches priced between about $127.17 and $136.00 per share.

The reporting person holds direct and indirect interests through the Brannin J. McBee 2022 Irrevocable Trust and several family trusts; some shares remain indirectly held for family trusts. The Form 4 was signed by an attorney-in-fact on 09/25/2025 and discloses that the sales were effected pursuant to a 10b5-1 trading plan adopted May 20, 2025.

CoreWeave (CRWV) and Core Scientific (CORZ) have entered into a definitive merger agreement under which Merger Sub will merge into Core Scientific and Core Scientific will become a wholly owned subsidiary of CoreWeave. Each outstanding share of Core Scientific common stock (other than excluded shares) will be converted into the right to receive 0.1235 shares of CoreWeave common stock. Based on CoreWeave’s closing price of $165.20 on July 3, 2025, the exchange ratio implied approximately $20.40 per Core Scientific share. The Core Scientific board unanimously recommends the Merger and received fairness opinions from Moelis and PJT Partners. The transaction requires Core Scientific stockholder approval, regulatory clearances including the HSR waiting period, effectiveness of the S-4 registration statement, Nasdaq listing approval for issued CoreWeave shares, and other customary conditions. Core Scientific stockholders have no dissenters’ or appraisal rights and certain Core Scientific equity awards and convertible notes will be adjusted or converted per the Merger Agreement. A $270 million termination fee applies in specified circumstances.